Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

被引:138
作者
Fiedler, Georg Martin [1 ]
Baumann, Sven [1 ]
Leichtle, Alexander [1 ]
Oltmann, Anke [1 ]
Kase, Julia [1 ]
Thiery, Joachim [1 ]
Ceglarek, Uta [1 ]
机构
[1] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04103 Leipzig, Germany
关键词
D O I
10.1373/clinchem.2006.077834
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Peptidome profiling of human urine is a promising tool to identify novel disease-associated biomarkers; however, a wide range of preartalytical variables influence the results of peptidome analysis. Our aim was to develop a standardized protocol for reproducible urine peptidome profiling by means of magnetic bead (MB) separation followed by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS). Methods: MBs with defined surface functionalities (hydrophobic interaction, cation exchange, and metal ion affinity) were used for peptide fractionation of urine. Mass accuracy and imprecision were calculated for 9 characteristic mass signals (M-r, 1000-10000). Exogenous variables (instrument performance, urine sampling/storage conditions, freezing conditions, and freeze-thaw cycles) and endogenous variables (pH, urine salt and protein concentrations, and blood and bacteria interferences) were investigated with urine samples from 10 male and 10 female volunteers. Results: We detected 427 different mass signals in the urine of healthy donors. Within- and between-day imprecision in relative signal intensities ranged from 1% to 14% and from 4% to 16%. respectively. Weak cation-exchange and metal ion affinity MB preparations required adjustment of the urinary pH to 7. Storage time, storage temperature, the number of freeze-thaw cycles, and bacterial and blood contamination significantly influenced urine peptide patterns. Individual urine peptide patterns differed significantly within and between days. This imprecision was diminished by normalization to a urinary protein content of 3.5 mu g. Conclusion: This reliable pretreatment protocol allows standardization of preartalytical modalities and facilitates reproducible peptidome profiling of human urine by means of MB separation in combination with MALDI-TOF MS. (c) 2007 American Association for Clinical Chemistry.
引用
收藏
页码:421 / 428
页数:8
相关论文
共 32 条
  • [1] The use of proteomics for the assessment of clinical samples in research
    Aldred, S
    Grant, MM
    Griffiths, HR
    [J]. CLINICAL BIOCHEMISTRY, 2004, 37 (11) : 943 - 952
  • [2] Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
    Baumann, S
    Ceglarek, U
    Fiedler, GM
    Lembcke, J
    Leichtle, A
    Thiery, J
    [J]. CLINICAL CHEMISTRY, 2005, 51 (06) : 973 - 980
  • [3] Biomedical informatics for proteomics
    Boguski, MS
    McIntosh, MW
    [J]. NATURE, 2003, 422 (6928) : 233 - 237
  • [4] Celis JE, 2000, ELECTROPHORESIS, V21, P2115
  • [5] Mass Spectrometry as a diagnostic and a cancer biomarker discovery tool - Opportunities and potential limitations
    Diamandis, EP
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (04) : 367 - 378
  • [6] Preanalytical impact of sample handling on proteome profiling experiments with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
    Findeisen, P
    Sismanidis, D
    Riedl, M
    Costina, V
    Neumaier, M
    [J]. CLINICAL CHEMISTRY, 2005, 51 (12) : 2409 - 2411
  • [7] Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy
    Haubitz, M
    Wittke, S
    Weissinger, EM
    Walden, M
    Rupprecht, HD
    Floege, J
    Haller, H
    Mischak, H
    [J]. KIDNEY INTERNATIONAL, 2005, 67 (06) : 2313 - 2320
  • [8] Proteomics: A new diagnostic frontier
    Hortin, GL
    Jortani, SA
    Ritchie, JC
    Valdes, R
    Chan, DW
    [J]. CLINICAL CHEMISTRY, 2006, 52 (07) : 1218 - 1222
  • [9] Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice?
    Hortin, GL
    [J]. CLINICAL CHEMISTRY, 2005, 51 (01) : 3 - 5
  • [10] Size-selective extraction of peptides from urine for mass spectrometric analysis
    Hortin, GL
    Meilinger, B
    Drake, SK
    [J]. CLINICAL CHEMISTRY, 2004, 50 (06) : 1092 - 1095